Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Quality of life and local treatment of oligometastatic prostate cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.05.19
Views: 161

Prof Claude Abbou - Clinique de l'Alma, Paris, France

Prof Claude Abbou speaks to ecancer at the 2019 International Gastrointestinal, Liver and Uro-Oncology Conference (IGILUC) in Cairo about quality of life after radical prostatectomy and local treatment in oligometastatic prostate cancer.

Prof Abbou explains the importance of understanding the patient's quality of life after surgery, but also to consider the impact on the patient's family too.

He also discusses the difficulty in treating advanced oligometastatic disease and how the primary tumour should be treated to reduce the risk of dissemination.


Related videos

follow us

Tobacco Dependence e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation